Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Short term Debt (2016 - 2018)

Cardiff Oncology's Short term Debt history spans 6 years, with the latest figure at $1.2 million for Q1 2018.

  • For Q1 2018, Short term Debt fell 69.67% year-over-year to $1.2 million; the TTM value through Mar 2018 reached $1.2 million, down 69.67%, while the annual FY2017 figure was $1.3 million, 43.58% down from the prior year.
  • Short term Debt for Q1 2018 was $1.2 million at Cardiff Oncology, down from $1.3 million in the prior quarter.
  • Across five years, Short term Debt topped out at $6.1 million in Q2 2016 and bottomed at $200792.0 in Q1 2014.
  • The 5-year median for Short term Debt is $1.9 million (2014), against an average of $2.4 million.
  • The largest annual shift saw Short term Debt soared 1426.32% in 2015 before it tumbled 78.61% in 2016.
  • A 5-year view of Short term Debt shows it stood at $1.9 million in 2014, then surged by 97.27% to $3.7 million in 2015, then tumbled by 36.98% to $2.4 million in 2016, then plummeted by 43.58% to $1.3 million in 2017, then dropped by 11.76% to $1.2 million in 2018.
  • Per Business Quant, the three most recent readings for CRDF's Short term Debt are $1.2 million (Q1 2018), $1.3 million (Q4 2017), and $1.5 million (Q3 2017).